June 26, 2025

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a 68% Upside Potential in the Healthcare Sector

Viemed Healthcare, Inc. (NASDAQ: VMD) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Lafayette, Louisiana, Viemed focuses on providing home..

Aurora Cannabis Inc. (ACB): Investor Outlook on This Canadian Cannabis Specialist

In the ever-evolving landscape of cannabis production, Aurora Cannabis Inc. (NASDAQ: ACB) stands out as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing..

Viant Technology Inc. (DSP)

⚠️ No article content returned.

..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a Biotech with a 190% Potential Upside

Heron Therapeutics, Inc. (NASDAQ: HRTX) stands at a pivotal juncture, poised to capture the attention of savvy investors with its compelling 190.70% potential upside. This biotechnology firm, nestled in the..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 27.95% Potential Upside in Healthcare Technology

TruBridge, Inc. (NASDAQ: TBRG), a key player in the Healthcare Information Services sector, has been garnering attention among investors with a notable potential upside of 27.95%, according to recent analyst..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating Challenges with a Strategic Global Presence

AMTD Digital Inc. (HKD), headquartered in Paris, France, operates within the technology sector, specifically in the Software – Application industry. Despite its relatively modest market capitalization of $562.56 million, the..

Sanara MedTech Inc. (SMTI) Investor Outlook: Exploring a 74% Upside Potential in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI) is a compelling player in the healthcare sector, specializing in innovative medical instruments and supplies. With its headquarters in Fort Worth, Texas, the company is..

Grab Holdings Limited (GRAB) Stock Analysis: Unveiling a 26% Potential Upside for Investors

Grab Holdings Limited (NASDAQ: GRAB) is capturing investor attention with its significant growth trajectory and a noticeable potential upside of 26.41%. As a prominent player in the Technology sector, focusing..

Aura Biosciences, Inc. (AURA) Stock Analysis: Uncovering a 227% Potential Upside in Biotechnology

Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, primarily due to its innovative approach towards treating solid tumors. As a clinical-stage company, Aura is on the cusp..

Materialise NV (MTLS) Stock Analysis: Exploring a 72% Upside Potential in the 3D Printing Sector

Materialise NV (NASDAQ: MTLS), a prominent player in the 3D printing industry, is capturing investor attention with its promising upside potential of 72%. The Belgian-based company, with a market capitalization..

Quantum-Si Incorporated (QSI) Investor Outlook: Exploring a 40% Upside Potential

Quantum-Si Incorporated (QSI), a healthcare sector innovator in the medical devices industry, is making waves with its cutting-edge single-molecule detection platform designed to revolutionize Next Generation Protein Sequencing (NGPS). With..

Alumis Inc. (ALMS) Stock Analysis: Exploring a Potential 617% Upside in the Biotech Sector

Alumis Inc. (NASDAQ: ALMS), a clinical-stage biopharmaceutical company, is creating waves in the biotechnology industry with its promising pipeline focused on autoimmune disorders. Despite its current price of $2.93, the..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a Potential 278.67% Upside Opportunity

aTyr Pharma, Inc. (NASDAQ: ATYR) is making waves in the biotechnology sector with its groundbreaking approach to treating fibrosis and inflammation. Based in San Diego, California, this clinical-stage biotech company..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Exploring a 391% Potential Upside in the Biotech Arena

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company, has captured the attention of investors with its oncology-focused pipeline and a remarkable potential upside of nearly 391.53%. As the company..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Exploring the 9.56% Potential Upside in the Biotech Innovator

For investors keeping a close watch on the healthcare sector, iTeos Therapeutics, Inc. (NASDAQ: ITOS) presents a intriguing opportunity within the biotechnology industry. With a market capitalization of $384.27 million,..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Unpacking a Potential 459% Upside

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its ambitious focus on developing treatments for pulmonary arterial hypertension (PAH). This San..

Neuronetics, Inc. (STIM) Stock Analysis: Aiming for a 99.8% Upside in the Medical Devices Sector

Neuronetics, Inc. (NASDAQ: STIM), based in Malvern, Pennsylvania, has carved a niche in the healthcare sector with its innovative NeuroStar Advanced Therapy System. This medical device uses transcranial magnetic stimulation..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a Potential 346.74% Upside in the Biotech Sector

Candel Therapeutics, Inc. (NASDAQ: CADL) is making waves in the biotechnology sector with its innovative approach to cancer treatment through immunotherapy. As the company continues to advance its clinical-stage biopharmaceutical..

Neurogene Inc. (NGNE) Stock Analysis: Unveiling a 159.68% Potential Upside in the Biotech Sector

Neurogene Inc. (NASDAQ: NGNE) is capturing the attention of investors with a compelling potential upside of 159.68%. As a clinical-stage biotechnology company, Neurogene is at the forefront of developing genetic..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 148.87% Potential Upside in Biotech

In the dynamic world of biotechnology, CytomX Therapeutics, Inc. (NASDAQ: CTMX) emerges as a noteworthy player with its innovative approach to cancer treatment. Operating at the forefront of biopharmaceutical developments,..

Search

Funds

June 26, 2025

Search

Funds

June 26, 2025

FTSE 100

Funds